The Dark Side of Blocking RAS in Diabetic Patients with Incipient or Manifested Nephropathy. [electronic resource]
Producer: 20170310Description: 350-60 p. digitalISSN:- 1439-3646
- Angiotensin Receptor Antagonists -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Diabetic Nephropathies -- drug therapy
- Humans
- Receptors, Cell Surface -- antagonists & inhibitors
- Renin-Angiotensin System -- drug effects
- Vacuolar Proton-Translocating ATPases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.